Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LivaNova PLCLIVN · Entity 507 | Director | June 15, 2026 | June 17, 2026 |
| METLIFE INCMET · Entity 488 | EVP & Chief HR Officer | March 01, 2024 | March 05, 2024 |
| Tevogen Inc.TVGN · Entity 7276 | Director | September 11, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LivaNova PLC
Report date June 15, 2026 · Filed June 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 5,642 |
Ending reported balance
After 2026-06-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-15 · Exercise / conversion · Acquired 4,042 · Balance 6,128 F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value. F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. Row 2 · 2026-06-15 · Tax withholding · Disposed 486 · Balance 5,642 F3: Shares withheld to satisfy tax liability. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-15 · Exercise / conversion · Disposed 4,042 · Balance 0 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,383 |
Reported balance
After 2026-06-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-15 · Grant · Acquired 2,383 · Balance 2,383 F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement. F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.
F2: Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.
F3: Shares withheld to satisfy tax liability.
F4: RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026.
F5: The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.
METLIFE INC
Report date March 01, 2024 · Filed March 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 79,794 |
Reported balance
After 2024-03-01 transaction · row 1
1 source rowRow 1 · 2024-03-01 · Tax withholding · Disposed 1,907 · Balance 79,794 F1: Withheld for taxes on shares issued for restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withheld for taxes on shares issued for restricted stock units.
Tevogen Inc.
Report date September 11, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,678 |
Reported balance
After 2026-09-11 transaction · row 1
1 source rowRow 1 · 2026-09-11 · Grant · Acquired 75,000 · Balance 123,678 F1: Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the Tevogen Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on September 11, 2027, provided that the reporting person remains in service with the Issuer at such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2019 Filed Feb 28, 2019 23:54 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 12,097 | $0.00 Strike: $44.65 | $0.00 |
DisclosureSEC source: 0001209191-19-014762 · doc4.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,097 Underlying: Common Stock · 12,097 shares Expires 2029-02-25 F1 · derivative.exercise_date: The options become exercisable in three installments on February 26, 2020, 2021 and 2020. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:42 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 1,649 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017302 · doc4.xml · derivative · entry 2 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,649 Underlying: Common Stock · 1,649 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. F3 · derivative.expiration_date: The Restricted Stock Units vest in three installments on March 1, 2019, 2020 and 2021. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 21:42 UTC | METLIFE INC MET · Entity 488 | GrantEmployee Stock Option (Right to Buy) · Derivative | 4,944 | $0.00 Strike: $45.50 | $0.00 |
DisclosureSEC source: 0001209191-18-017302 · doc4.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,944 Underlying: Common Stock · 4,944 shares Expires 2028-03-01 F1 · derivative.exercise_date: The options become exercisable in three installments on March 2, 2019, 2020 and 2021. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:18 UTC | METLIFE INC MET · Entity 488 | GrantRestricted Stock Units · Derivative | 26,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-044772 · doc4.xml · derivative · entry 1 PODLOGAR SUSAN M · CIK 0001709959 · EVP & Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,762 Underlying: Common Stock · 26,762 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F1 · price: Each Restricted Stock Unit is the contingent right to receive one share of MetLife, Inc. common stock. F2 · derivative.exercise_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares. F2 · derivative.expiration_date: The award of Restricted Stock Units will "cliff vest" on July 10, 2020 and will be payable 100% in shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.